Abstract
KRAS-induced actin-interacting protein (KRAP), originally identified as one of the deregulated genes expressed in colorectal cancer, participates under physiological conditions in the regulation of systemic energy homeostasis and of the exocrine system. We have recently found that KRAP is a molecule associated with inositol 1,4,5-trisphosphate receptor (IP3R) and is critical for the proper subcellular localization of IP3R in the liver and the pancreas. However, the expression of KRAP and its precise function in other tissues remain elusive. In this study, we aimed to identify the KRAP-expressing cells in mouse stomach and kidneys and to examine the relevance of KRAP expression in the regulation of IP3R localization in these tissues. In the stomach, double immunohistochemical staining for KRAP and IP3R demonstrated that KRAP was expressed along with the apical regions in the mucous cells and the chief cells, and IP3R3 was dominantly co-localized with KRAP in these cells. Furthermore, IP3R2 was also co-localized with IP3R3 in the chief cells. It is of note that the proper localization of IP3R3 and IP3R2 in the chief cells and of IP3R3 in the mucous cells were significantly abrogated in KRAP-deficient mice. In the kidneys, KRAP was expressed in both the apical and the basal regions of the proximal tubular cells. Intriguingly, KRAP deficiency abrogated the localization of IP3R1 in the proximal tubular cells. Finally, co-immunoprecipitation study in the stomachs and the kidneys validated the physical association of KRAP with IP3Rs. These findings demonstrate that KRAP physically associates with IP3Rs and regulates the proper localization of IP3Rs in the mucous cells and the chief cells of the stomach and in the proximal tubular cells of the kidneys.
Keywords: RAS-induced actin-interacting protein; inositol 1,4,5-trisphosphate receptor; immunohistochemical staining; protein-protein interaction; stomach; kidney
Introduction
Three inositol 1,4,5-trisphosphate receptor (IP3R) subtypes, IP3R1, IP3R2, and IP3R3, are differentially expressed among tissues (1–5) and function as the Ca2+ release channel on endoplasmic reticulum membranes (6–10). IP3R is regulated by many intracellular modulators, phosphorylation by kinases, and associated proteins (11–15).
KRAS-induced actin-interacting protein (KRAP) was originally identified as one of the deregulated expression gene in the colorectal cancer cell line, HCT116 (16). The previous studies using KRAP-knockout (KRAP-KO) mice demonstrate that KRAP participates in the regulation of systemic energy homeostasis (17) and of exocrine system (18). Among the adult mouse tissues, KRAP is ubiquitously expressed, with high levels in the pancreas, liver, and brown adipose tissues, and KRAP localizes in the restricted apical regions of the liver parenchymal cells and of the pancreatic exocrine acinar cells (19). Our recent findings indicate that KRAP associates with IP3R to regulate its proper subcellular localization in the mouse liver and the pancreas (20) as well as in immortalized cultured cell lines (21). Despite these advances, it remains largely unknown which cell types express KRAP among the other tissues including stomach and kidneys.
Herein, we performed immunohistological analysis and identified the exact KRAP-expressing cells in the stomach and the kidneys, and demonstrated that KRAP plays critical role in the regulation of the precise subcellular localization of IP3R in the mucous and the chief cells of the stomach and in the proximal tubular cells of the kidneys.
Materials and methods
Animals
All animals used in this study were treated in accordance with the guidelines of Fukuoka University. KRAP-knockout mice were generated as described previously (17).
Immunohistochemical staining
Immunohistochemical staining was performed as described previously (19,20). Specific signals were detected by using rabbit polyclonal anti-KRAP antibody (19), mouse monoclonal anti-ZO-1 antibody (ZYMED), mouse monoclonal anti-IP3R3 antibody (610313) from BD Transduction Laboratories, rabbit polyclonal anti-IP3R2 antibody (AB3000) from Millipore, and rabbit polyclonal anti-IP3R1 antibody (ab5840) from Abcam.
Immunoprecipitations and western blotting
Immunoprecipitations and western blotting were performed as described previously (19,20).
Results
Localization of KRAP protein in the adult mouse stomach
To examine the cellular distribution of KRAP protein in the adult mouse tissues, we performed immunohistochemical staining by using anti-KRAP antibody. In the stomach, strong KRAP immunoreactivity was restricted to the pit regions of gastric glands (Fig. 1A), whereas significant expression of KRAP was not detected in the muscularis mucosae beneath the gastric glands (Fig. 1A, arrows). The specificity of KRAP expression in the stomach was confirmed by using KRAP-KO tissue as a control (Fig. 1B). In the pit region of the gastric gland, where columnar surface mucous cells mainly exist (22), KRAP was localized beneath the apical membranes of the mucous cells (Fig. 1C). In the base region of the gastric glands, where zymogenic chief cells mainly exist, coronal plane of deeper gastric glands showed that KRAP was restricted to the apical regions of the chief cells (Fig. 1D, arrowheads), whereas KRAP was not detected in the parietal cells (Fig. 1D, asterisks). The distinction between the chief and the parietal cells was validated by ZO-1 staining as described (23), indicating that KRAP was expressed in the ZO-1-positive chief cells but not in the ZO-1-negative parietal cells (Fig. 1E).
KRAP co-localized with IP3R in the stomach
Since we previously reported that KRAP associates with particular subtypes of IP3R in the liver and the pancreas (20), we examined whether KRAP in the stomach is also co-localized with IP3R. Double-immunostaining of the stomach for KRAP and IP3R3 revealed that KRAP was co-localized with IP3R3 in the apical regions of both the chief cells (Fig. 2A, arrows) and the mucous cells (Fig. 2B, arrows). Of note, IP3R2 co-existed with IP3R3 in the chief cells (Fig. 2C, arrow) but not in the parietal cells (Fig. 2C, asterisks). Furthermore, IP3R2 was not detected in the mucous cells (Fig. 2D, arrows). These results indicated that KRAP was co-localized with IP3R2 and IP3R3 in the chief cells and with IP3R3 in the mucous cells.
Impaired localization of IP3R in the KRAP-deficient chief cells and the mucous cells
We addressed the functional relevance of KRAP to the proper localization of IP3R by using KRAP-KO mice. IP3R3 was located in the apical region of the chief cells (Fig. 3A, arrow) and of the mucous cells (Fig. 3C, arrows) in the wild-type (WT) mouse stomach, whereas the restricted localization of IP3R3 appeared to be diminished in the KRAP-KO stomach (Fig. 3B, arrow; 3D, arrows). Furthermore, IP3R2 was detected in both the chief cells (Fig. 3E, arrows) and the parietal cells (Fig. 3E, asterisks) in the WT stomach, whereas the localization of IP3R2 in the KRAP-KO stomach was impaired in the chief cells (Fig. 3F, arrows) but not in the parietal cells (Fig. 3F, asterisks). Thus, KRAP plays critical role in the regulation of the proper localization of IP3R2 and IP3R3 in the chief cells and of IP3R3 in the mucous cells.
KRAP expression and its contribution to the localization of IP3R1 in the proximal tubules of the mouse kidney
To examine the cellular distribution of KRAP protein in the adult mouse kidneys, we performed immunohistochemical staining by using anti-KRAP antibody. The specificities of the signals were validated by comparing the immunoreactivities of WT and KRAP-KO mouse tissues. In the WT kidneys, intense immunoreactivities were observed in the renal proximal tubules (Fig. 4A) but not in the renal distal tubules (data not shown). On the other hand, significant immunoreactive signal was not detected in the proximal tubules in the KRAP-KO mice (Fig. 4B). Taken together, these results indicate that KRAP was exactly expressed in the proximal tubules. The proximal tubules were identified by the presence of the brush-border stained with phalloidin (Fig. 4A and B). Immunostaining in the proximal region showed that KRAP was accumulated beneath the brush-border (Fig. 4A, arrows) and KRAP was also detected in the basolateral actin bundles (Fig. 4A, arrowheads). We next examined which subtypes of IP3R, IP3R1, IP3R2, and IP3R3, expressed in the proximal tubular cells, revealing that IP3R1 (Fig. 4C) but not IP3R 2 or IP3R3 (data not shown) was detected in the beneath the brush-border and in the basolateral actin bundles. Finally, we addressed the functional relevance of KRAP expression in the proximal tubular cells to the regulation of IP3R localization. It is of note that the restricted localization of IP3R1 detected in the WT mouse kidney (Fig. 4C) was disturbed in the KRAP-KO mouse kidney (Fig. 4D). Thus, KRAP plays critical role in the regulation of the proper localization of IP3R1 in the proximal tubular cells.
KRAP interacts with IP3R1 in the kidneys and with IP3R3 in the stomach
As described above, immunohistochemical signals for particular IP3R subtypes in the KRAP-KO mouse kidneys or the stomach were abrogated, leading us to check the expression levels of IP3R between the WT and KRAP-KO mouse tissues. Normal expression levels of IP3R1 and IP3R3 were detected in the KRAP-KO mouse kidney and the stomach, respectively, compared with the WT mouse tissues (Fig. 5A), suggesting that mislocalizations but not deregulated expressions of IP3R occur in the KRAP-KO mouse kidneys and the stomach. Next, to examine the physical association of KRAP with IP3R, we performed co-immunoprecipitations by anti-KRAP antibody in the kidneys or the stomach, in which we could not evaluate the specific association of IP3R2 with KRAP due to lack of IP3R2-specific antibody available for western blotting. In the preparations from the WT mouse tissues, KRAP precipitates IP3R1 and IP3R3 in the kidney and the stomach, respectively (Fig. 5B). The specificity of co-immunoprecipitations of IP3R was confirmed by using KRAP-KO mouse tissue as a control (Fig. 5B). Thus, KRAP physically interacts with IP3R1 in the kidneys and with IP3R3 in the stomach.
Discussion
In this study, we demonstrated that KRAP protein expression and the subcellular localization was restricted beneath the apical and/or basolateral membranes in specific cell types of the stomach and the kidneys, in which KRAP physically associated with particular IP3R subtype(s). In the KRAP-KO mouse stomach and the kidneys, the polarized localization of IP3R was impaired, indicating that KRAP plays critical roles in the regulation of the proper subcellular localization of IP3R in the stomach and the kidneys.
Notably, KRAP as well as IP3R3 proteins were polarized beneath the apical membranes facing the gastric gland lumen and were absent in the parietal cells (Fig. 1), suggesting an association of these proteins with chief cell functions including pepsinogen secretion (22–24). From this view point, KRAP expression and the localization beneath the apical membranes of the pancreatic acinar cells (19), another type of zymogen cells, may suggest a similar role for KRAP in the stomach and the pancreas. Considering the fact that KRAP physically interacts with IP3R to regulate its proper localization in these tissues, stomach (Figs. 2, 3 and 5) and pancreas (20), and that double-knockout of IP3R2 and IP3R3 in mice revealed a failure in secretory function in the pancreas (25), KRAP seems to be involved in the exocrine systems. Actually, the pancreatic acinar cells in KRAP-KO mice showed an increased amount of zymogen granules, although they seemed to maintain the proper physiological agonist-induced exocytosis (18). Thus, exact functional relevance of KRAP and its interaction with IP3R to the exocrine systems in the pancreas and the stomach should await future studies.
It is of note that KRAP was restricted to both the apical region and the basolateral region of the proximal tubular cells of the kidneys (Fig. 4), and that KRAP physically associated with IP3R1 in the kidneys (Fig. 5). Furthermore, our previous study showed that KRAP was distributed along the bile canaliculi of hepatocytes and underneath the apical membrane of pancreatic acinar cells (19). All these KRAP localizations in the distinct tissues examined are restricted to epithelial cell types bearing well-developed cell polarity, cell-cell junction and microvilli, where transports of various substances between epithelial cells and extracellular spaces, exocrine space or blood stream occur (22,26–28). Since KRAP-KO mice displayed profound metabolic disorders after birth without developmental defects, and certain systemic inter-tissue dysregulations appeared to underlie the metabolic phenotypes (17), KRAP might play physiological roles in secretion and/or absorption functions after birth rather than in developmental events.
Renal proximal tubules serve the reabsorption of the bulk of substances filtered in the glomeruli and the excretion (26,29). These two opposite transports are accomplished by the coordinated action of ion channels and transporters located in the brush border membrane and basolateral membrane (29–31). Thus, the polarized expression of these membrane proteins is crucial for the function of the proximal tubules. Based on the findings that KRAP protein possesses characteristic features like scaffolding protein, such as polarized localization and transporting of IP3R, potential functional relevance of KRAP to these processes would be suspected.
In conclusion, we identified the exact KRAP-expressing cells in the stomach and the kidneys, and found that KRAP physically associates with IP3R to regulate its proper subcellular localization in vivo. Considering the KRAP function as an IP3R regulator and the importance of KRAP in energy homeostasis in vivo, further research on the exact relevance of the association between KRAP and IP3R to the biological phenomena will lead to a better understanding of physiological metabolic processes.
Acknowledgments
This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities, a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. We thank Takami Danno and Yoko Tanaka for their technical assistance.
References
- 1.Ross CA, Danoff SK, Schell MJ, Snyder SH, Ullrich A. Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proc Natl Acad Sci USA. 1992;89:4265–4269. doi: 10.1073/pnas.89.10.4265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sharp AH, McPherson PS, Dawson TM, Aoki C, Campbell KP, Snyder SH. Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca2+ release channels in rat brain. J Neurosci. 1993;13:3051–3063. doi: 10.1523/JNEUROSCI.13-07-03051.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sugiyama T, Yamamoto-Hino M, Miyawaki A, Furuichi T, Mikoshiba K, Hasegawa M. Subtypes of inositol 1,4,5-trisphosphate receptor in human hematopoietic cell lines: dynamic aspects of their cell-type specific expression. FEBS Lett. 1994;349:191–196. doi: 10.1016/0014-5793(94)00662-8. [DOI] [PubMed] [Google Scholar]
- 4.Newton CL, Mignery GA, Südhof TC. Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3. J Biol Chem. 1994;269:28613–28619. [PubMed] [Google Scholar]
- 5.Wojcikiewicz RJ. Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types. J Biol Chem. 1995;270:11678–11683. doi: 10.1074/jbc.270.19.11678. [DOI] [PubMed] [Google Scholar]
- 6.Jayaraman T, Ondriasová E, Ondrias K, Harnick DJ, Marks AR. The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling. Proc Natl Acad Sci USA. 1995;92:6007–6011. doi: 10.1073/pnas.92.13.6007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatini DM, Li SH, Ross CA, Snyder SH. Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science. 1996;273:503–507. doi: 10.1126/science.273.5274.503. [DOI] [PubMed] [Google Scholar]
- 8.Sugawara H, Kurosaki M, Takata M, Kurosaki T. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J. 1997;16:3078–3088. doi: 10.1093/emboj/16.11.3078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Scharenberg AM, Humphries LA, Rawlings DJ. Calcium signalling and cell-fate choice in B cells. Nat Rev Immunol. 2007;7:778–789. doi: 10.1038/nri2172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.deSouza N, Cui J, Dura M, McDonald TV, Marks AR. A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation. J Cell Biol. 2007;179:923–934. doi: 10.1083/jcb.200708200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Patterson RL, Boehning D, Snyder SH. Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem. 2004;73:437–465. doi: 10.1146/annurev.biochem.73.071403.161303. [DOI] [PubMed] [Google Scholar]
- 12.Bezprozvanny I. The inositol 1,4,5-trisphosphate receptors. Cell Calcium. 2005;38:261–272. doi: 10.1016/j.ceca.2005.06.030. [DOI] [PubMed] [Google Scholar]
- 13.Foskett JK, White C, Cheung KH, Mak DO. Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev. 2007;87:593–658. doi: 10.1152/physrev.00035.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Mikoshiba K. IP3 receptor/Ca2+ channel: from discovery to new signaling concepts. J Neurochem. 2007;102:1426–1446. doi: 10.1111/j.1471-4159.2007.04825.x. [DOI] [PubMed] [Google Scholar]
- 15.Zhang S, Fritz N, Ibarra C, Uhlén P. Inositol 1,4,5-trisphosphate receptor subtype-specific regulation of calcium oscillations. Neurochem Res. 2011;36:1175–1185. doi: 10.1007/s11064-011-0457-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Inokuchi J, Komiya M, Baba I, Naito S, Sasazuki T, Shirasawa S. Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells. J Hum Genet. 2004;49:46–52. doi: 10.1007/s10038-003-0106-3. [DOI] [PubMed] [Google Scholar]
- 17.Fujimoto T, Miyasaka K, Koyanagi M, Tsunoda T, Baba I, Doi K, Ohta M, et al. Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice. PLoS One. 2009;4:e4240. doi: 10.1371/journal.pone.0004240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Miyasaka K, Fujimoto T, Kawanami T, Takiguchi S, Jimi A, Funakoshi A, Shirasawa S. Pancreatic hypertrophy in Ki-ras-induced actin-interacting protein gene knockout mice. Pancreas. 2011;40:79–83. doi: 10.1097/MPA.0b013e3181f66c22. [DOI] [PubMed] [Google Scholar]
- 19.Fujimoto T, Koyanagi M, Baba I, Nakabayashi K, Kato N, Sasazuki T, Shirasawa S. Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line. J Hum Genet. 2007;52:978–984. doi: 10.1007/s10038-007-0204-8. [DOI] [PubMed] [Google Scholar]
- 20.Fujimoto T, Machida T, Tanaka Y, Tsunoda T, Doi K, Ota T, Okamura T, et al. KRAS-induced actin-interacting protein is required for the proper localization of inositol 1,4,5-trisphosphate receptor in the epithelial cells. Biochem Biophys Res Commun. 2011;407:438–443. doi: 10.1016/j.bbrc.2011.03.065. [DOI] [PubMed] [Google Scholar]
- 21.Fujimoto T, Machida T, Tsunoda T, Doi K, Ota T, Kuroki M, Shirasawa S. Determination of the critical region of KRAS-induced actin-interacting protein for the interaction with inositol 1,4,5-trisphosphate receptor. Biochem Biophys Res Commun. 2011;408:282–286. doi: 10.1016/j.bbrc.2011.04.016. [DOI] [PubMed] [Google Scholar]
- 22.Mills JC, Andersson N, Stappenbeck TS, Chen CC, Gordon JI. Molecular characterization of mouse gastric zymogenic cells. J Biol Chem. 2003;278:46138–46145. doi: 10.1074/jbc.M308385200. [DOI] [PubMed] [Google Scholar]
- 23.Zhu L, Hatakeyama J, Zhang B, Makdisi J, Ender C, Forte JG. Novel insights of the gastric gland organization revealed by chief cell specific expression of moesin. Am J Physiol Gastrointest Liver Physiol. 2009;296:G185–G195. doi: 10.1152/ajpgi.90597.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Schubert ML. Gastric exocrine and endocrine secretion. Curr Opin Gastroenterol. 2009;25:529–536. doi: 10.1097/MOG.0b013e328331b62a. [DOI] [PubMed] [Google Scholar]
- 25.Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, Kitaguchi T, et al. IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science. 2005;309:2232–2234. doi: 10.1126/science.1114110. [DOI] [PubMed] [Google Scholar]
- 26.Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev. 2004;84:987–1049. doi: 10.1152/physrev.00040.2003. [DOI] [PubMed] [Google Scholar]
- 27.Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res. 2007;24:1803–1823. doi: 10.1007/s11095-007-9289-1. [DOI] [PubMed] [Google Scholar]
- 28.Husain S, Thrower E. Molecular and cellular regulation of pancreatic acinar cell function. Curr Opin Gastroenterol. 2009;25:466–471. doi: 10.1097/MOG.0b013e32832ebfac. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Anzai N, Jutabha P, Kanai Y, Endou H. Integrated physiology of proximal tubular organic anion transport. Curr Opin Nephrol Hypertens. 2005;14:472–479. doi: 10.1097/01.mnh.0000170751.56527.7e. [DOI] [PubMed] [Google Scholar]
- 30.Hernando N, Wagner CA, Gisler SM, Biber J, Murer H. PDZ proteins and proximal ion transport. Curr Opin Nephrol Hypertens. 2004;13:569–574. doi: 10.1097/00041552-200409000-00014. [DOI] [PubMed] [Google Scholar]
- 31.Brône B, Eggermont J. PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. Am J Physiol Cell Physiol. 2005;288:C20–C29. doi: 10.1152/ajpcell.00368.2004. [DOI] [PubMed] [Google Scholar]